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We investigate the temporal evolution of the distribution of immunities in a population, which is determined by various
epidemiological, immunological, and demographical phenomena: after a disease outbreak, recovered individuals constitute a
large immune population; however, their immunity is waning in the long term and they may become susceptible again.
Meanwhile, their immunity can be boosted by repeated exposure to the pathogen, which is linked to the density of infected
individuals present in the population. This prolongs the length of their immunity. We consider a mathematical model
formulated as a coupled system of ordinary and partial diﬀerential equations that connects all these processes and systematically
compare a number of boosting assumptions proposed in the literature, showing that diﬀerent boosting mechanisms lead to very
diﬀerent stationary distributions of the immunity at the endemic steady state. In the situation of periodic disease outbreaks, the
waveforms of immunity distributions are studied and visualized. Our results show that there is a possibility to infer the boosting
mechanism from the population level immune dynamics.
1. Introduction
The outcome of an infection within an individual host
depends on the speciﬁc pathogen and the status of the
immune system of the host. At a larger scale, the outcome
of an epidemic in a population is inﬂuenced by the ensemble
of individual immunities. There are a number of processes in
play that determine how these immunities change in time.
Upon recovery from infection, some immune memory
remains, which may persist for long time after pathogen
clearance. Eventually, memory cells slowly decay, and in the
long run, recovered hosts could lose pathogen-speciﬁc
immunity [1]. Waning immunity is possibly one of the
contributing factors which cause, in particular in highly
developed regions, recurrent outbreaks of infectious diseases
such as chickenpox and pertussis. Immune memory can
be boosted due to repeated exposure to the pathogen
thus prolonging the time during which immune hosts
are protected. Our goal in this paper is to monitor the
distributions of immune memories in a population and
track their temporal evolution, which provides very impor-
tant insights about the interplay of individual and population
level disease dynamics.
In the SIR framework, a population of hosts is divided
into susceptibles (S), infectives (I), and recovered (R), and
interactions among individuals from the diﬀerent compart-
ments are considered. Susceptibles are those hosts who either
have not contracted the disease in the past or have lost immu-
nity against the disease-causing pathogen.When a susceptible
host gets in contact with an infective, the pathogen can be
transmitted and the susceptible host may become infective.
After the loss of immunity, an individual from compartment
R transits back to the susceptible compartment; hence when
waning of immunity is included, the model is called SIRS.
To account for immune system boosting, we structure
the immunes according to their level of immunity. The
high complexity of the immune status of an individual is
simpliﬁed into a single parameter that reﬂects the strength
of immunity in the sense that it indirectly indicates the dura-
tion of immunity until waning. The challenge due to
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secondary or multiple exposures to the pathogen initiates an
immune response that results in a higher level of immunity.
The details are yet unclear how exactly the immune
response and in particular a boost of the immune system
work [1]; most likely, there is a range of mechanisms
underlying these processes that are speciﬁc to each host and
pathogen [2]. Laboratory analysis on vaccines tested on
animals or humans suggests that the boosting eﬃcacy
might depend on several factors, among which the current
immune status of the recovered host and the amount of
pathogen he receives [2, 3]. In previous mathematical models,
it was assumed that a boost restores the maximal immune
status, the same as after natural infection [4]. Few authors
have assumed that at each new contact with a known
pathogen, the immune system is boosted a little, with a
small increase in memory cells [5]. Others have considered
a combination of both possibilities [6].
To investigate the temporal evolution of how the distri-
bution of these immunity levels changes in the population,
we propose a mathematical modeling framework along the
lines of our previous works [7, 8]. The core of the model is
a hybrid system of equations of SIRS type, in which the
immune population is structured by the level of immunity,
whereas the susceptible and the infective populations are
nonstructured. In [8], we investigated the well-posedness
of the general model and its basic qualitative properties,
whereas in [7], we considered a special case of the hybrid
system in form of delay diﬀerential equations (DDEs) with
constant and distributed delay. Here, we focus on the
immune response identifying several possible scenarios for
immune system boosts.
We systematically compare a number of assumptions on
the boosting mechanism that have been used in the literature.
The goal is to observe the eﬀects of diﬀerent immune
responses not only at an individual but also at population
level, such as the stationary distribution of immunities in
the case of an endemic disease and the periodic change of
these distributions in case of repeated disease outbreaks. To
the best of our knowledge, there are no further studies about
the temporal evolution of the distribution of immune statuses
in a population, and the only paper that has predicted a spe-
ciﬁc immunity distribution from amathematical model is [6].
In Section 2, we provide the details of the mathematical
model and present the numerical methods that are used for
its solution. Four scenarios for immune boosting mecha-
nisms are described and compared in Section 3, together with
the parametrizations that lead to an either stable endemic
state or oscillatory disease outbreaks. A careful and system-
atic numerical analysis is performed to understand the eﬀect
of various boosting mechanisms, and the results are summa-
rized and discussed in Section 4.
2. Materials and Methods
2.1. The Mathematical Model. Let S t and I t denote the
total population of susceptibles and infectives, respectively,
at time t. The total population shall be assumed to be in
balance (hence normalized) N t ≡ 1, with birth rate equal
to the natural death rate d ≥ 0 and no disease-induced death.
We assume that newborns are all susceptible.
Contact with infectives (at rate βI) induces susceptible
hosts to become infective themselves. Infected hosts recover
at rate γ > 0, that is, 1/γ is the average infection duration.
Once recovered from the infection, individuals become
immune; however, there is no guarantee for life-long protec-
tion. Immune hosts who experience immunity loss become
susceptible again.
Let r t, z denote the density of immune individuals
at time t with immunity level z ∈ zmin, zmax , 0 ≤ zmin <
zmax <∞. The total population of immune hosts is given by
R t =
zmax
zmin
r t, z dz 1
The parameter z describes the immune status and can be
related to the number of speciﬁc immune cells of the host.
The value zmax corresponds to the maximal immunity,
whereas zmin corresponds to the lowest level of immunity
for hosts in the R compartment. We assume that individuals
who recover at time t enter the immune compartment with
maximal level of immunity zmax. The level of immunity tends
to decay in time and when it reaches the lower threshold zmin,
the host becomes susceptible again. However, contact with
infectives, or equivalently, exposure to the pathogen, can
boost the immune system from z ∈ zmin, zmax to any higher
immune status (see Figure 1).
Given a host with initial immune status v ∈ zmin, zmax ,
let us denote by Zv ∈ zmin, zmax the updated immune status,
which is achieved after new contact with the pathogen. The
updated immune status Zv is modeled as a random variable
taking values in Sv ≔ v, zmax ⊆ zmin, zmax ⊆ℝ with proba-
bility density function p ·, v . The value p z, v represents
the relative likelihood that a boost from immune level v to
level z occurs. Secondary exposures to the pathogen might
have no eﬀects on the host’s immune system or might restore
the immunity level induced by the disease (zmax). In order to
capture these particular aspects, in Section 3.1, we shall also
consider limit cases in which the probability density function
is a Dirac measure centered either on the current immune
status or on the maximal level zmax.
The immunity level decays in time at rate g z , with g
positive, smooth, and bounded, which is the same for all
immune individuals with immunity level z. In the absence
of immune system boosting, an infected host who recovered
at time t0 becomes again susceptible at time t0 + τ, where
τ =
zmax
zmin
1
g x
dx 2
With the above assumptions, we obtain for t > 0 the
following system of equations
S′ t = d 1 − S t − βS t I t + g zmin r t, zmin ,
I′ t = βS t I t − γ + d I t ,
3
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with initial values S 0 = S0 > 0, I 0 = I0 ≥ 0, coupled with a
partial diﬀerential equation (PDE) for the immune population,
∂
∂t
r t, z − ∂
∂z
g z r t, z = −dr t, z + βI t
z
zmin
p z, v r t, v dv − r t, z ,
4
for z ∈ zmin, zmax , with boundary condition
g zmax r t, zmax = γI t , 5
and initial distribution r 0, z = ψ z , z ∈ zmin, zmax . A
sketch of the full model is given in Figure 1, whereas some
possible boosting mechanisms are depicted in Figure 2, and
they will be discussed later in detail. The formal derivation
of a slightly more general version of models (3), (4), and (5)
with variable total population size and disease-induced death
is given in [8].
2.2. R0. Before presenting further results, we introduce the
basic reproduction numberR0 of models (3), (4), and (5),
R0 =
β
γ + d , 6
which indicates the average number of secondary infections
generated in a fully susceptible population by one infected
host over the course of his infection. The basic reproduction
number is a reference parameter in mathematical epidemiol-
ogy used to understand if, and in which proportion, the dis-
ease will spread among the population.
2.3. Numerical Solution of the Hybrid System. In the follow-
ing, we outline the numerical method used to solve the
hybrid system (3), (4), and (5).
Consider (3), (4), and (5) as a one-dimensional, ﬁrst-
order nonlinear PDE system. In this section, we refer to the
independent variables t, z as time and space, respectively.
As S and I do not depend on z, but only on time, the initial
conditions are
S 0, z ≡ S 0 ≡ S0 > 0,
I 0, z ≡ I 0 ≡ I0 ≥ 0,
r 0, z = ψ z , z ∈ zmin, zmax
7
Since g z > 0 for all z ∈ zmin, zmax , the boundary condi-
tion for r is imposed in (5) at the inﬂow boundary, that is, at
z = zmax. All together we have an initial-boundary value
problem (IBVP). For the numerical integration of the IBVP,
we employ the MATLAB code hpde [9], developed to solve
IBVPs for ﬁrst-order systems of hyperbolic PDEs in one
space variable and time. The hpde routine implements
Richtmyer’s two-step variant of the Lax-Wendroﬀ method
[10, 11], which is well established to solve hyperbolic PDEs.
This scheme is explicit and second-order accurate in both
space and time. To compute the numerical solution of our
IBVP, we have modiﬁed the code hpde so that the integral
term in (4) is eﬃciently implemented, preserving the
second-order accuracy of the Lax-Wendroﬀ scheme. In
Section 3.3, we have veriﬁed the spatial order of accuracy
for a number of computations.
In the computation of the numerical solutions of the
IBVP, we used an equidistant mesh zmin = ẑ0 < ẑ1 <⋯ <
ẑM = zmax,Δẑ = ẑi − ẑi−1,i = 1,… ,M The initial function on
this mesh is given by S 0 , I 0 , r 0, ẑi = S0, I0, ψ ẑi
For an explicit scheme for a hyperbolic system, a
necessary condition for stability is the Courant-Friedrichs-
Lewy condition, which for our system means
Δt
Δẑ maxẑ∈ ẑ0,…,ẑM
g ẑ < 1 8
We deﬁne the boosting matrix Π as the numerical
discretization of the probability density function p on the
zmin zmaxv z
Boosting
Waning
Figure 1: Sketch of the mathematical models (3), (4), and (5). Susceptible hosts become infective after pathogen transmission.
Infected hosts who recover enter the immune compartment R which is structured by the level of immunity. Natural infection
induces the maximal level of immunity zmax. Immunity decays in time and when the immune status reaches the minimal value
zmin; the recovered host becomes susceptible again. Meanwhile, exposure to the pathogen can boost the immune system and
prolong protection.
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equidistant mesh Δẑ. Each entry πij =Π i, j of the boosting
matrix represents the probability that ẑi is the updated
immune level, given initial immune level ẑ j, that is, πij =
p ẑi, ẑ j . It follows that πij ∈ 0, 1 , with πij = 0 if j > i and
〠
M
i=1
πij = 〠
M
i=j
πij = 1, for all j = 1,… ,M 9
3. Results and Discussion
3.1. Scenarios for the Immune Response. Let us consider an
immune host who has immune status v at the moment of
reexposure to the pathogen. We shall investigate the fol-
lowing possible scenarios for immune response in case of
secondary exposure to the pathogen.
3.1.1. NOboost. Assume that the immune system does not
respond to reinfection, that is, we observe only waning of
immunity after recovery (Figure 2(a)). This corresponds to
the limit case in which the boosting probability function is
simply a Dirac measure with support on the initial immune
level. It follows that (4) reduces to
∂
∂t
r t, z − ∂
∂z
g z r t, z = −dr t, z 10
Recall the deﬁnition of τ > 0 in (2). The transport
equation (10) with boundary condition (5) is solved along
characteristics and we obtain
g zmin r t, zmin = γI t − τ e−dτ, 11
meaning that τ time after recovery immune hosts who did
not die become susceptible again. In turn, we ﬁnd a delay
term in the equation for S and have a classical SIRS model
with constant delay (cf. [12])
S′ t = d − βS t I t − dS t + γI t − τ e−dτ,
I′ t = βS t I t − γ + d I t ,
R′ t = γI t − γI t − τ e−dτ − dR t ,
12
where R t is the total immune population at time t as in (1).
3.1.2. MAXboost. Assume that at any new encounter with the
pathogen the immune system of a recovered host is boosted
in such a way that the disease-induced (maximal) immunity
is restored (Figure 2(b)). This corresponds to the limit case in
which the boosting probability function is a Dirac measure
with support on the maximal immune level (zmax). As
Immunity loss
zmax
zmin
Memory cell
population
(slow decrease)
(a) No boosts
Immunity loss
zmax
zmin
Memory cell
population
(slow decrease)
Immune system
is boosted
(b) Boost to maximal level
Immunity loss
zmin
zmax
Memory cell
population
(slow decrease)
Immune system
is boosted
(c) Boost to any higher level
Figure 2: Exposure to the pathogen has a boosting eﬀect on the immune system, whereby several possible scenarios are possible: (a) No
boosting events (NOboost): the host who recovered at time t becomes susceptible at time t + τ, with τ > 0 given in (2). (b) Boosts restore
disease-induced immunity, that is, the immune system is always boosted to the maximal level of immunity (MAXboost). (c) Variable
boost, to any higher immune level.
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Figure 3: Nonmonotonic immune response mechanisms. (a, c, d) Examples of diﬀerent boosting matrices Π for the numerical
implementation of p z, v , the probability that individuals with immune level v at exposure are boosted to level z ≥ v after exposure. The
immune status is represented in zmin, zmax = 0, 1 and discretized on an equidistant mesh with 30 points. (b) The dotted curve represents
the boosting mechanism inspired by [6], the solid curve the one inspired by [14].
all boosted individuals are transferred to the boundary,
and the integral term in (4) moves to the boundary
condition, yielding
∂
∂t
r t, z − ∂
∂z
g z r t, z = −dr t, z − βI t r t, z , 13
g zmax r t, zmax = γI t + βI t R t 14
The BVP (13) and (14) can be solved along characteristics
and one obtains for t ≥ 0 a system of delay equations with
constant and distributed delay:
S′ t = d 1 − S t − βI t S t
+ I t − τ γ + βR t − τ e−dτ−β
0
−τ
I t+u du,
I′ t = βI t S t − γ + d I t ,
R′ t = −dR t + γI t
− I t − τ γ + βR t − τ e−dτ−β
0
−τ
I t+u du,
15
with τ > 0 as deﬁned in (2) and with given initial functions
ϕS t ≥ 0, ϕI t ≥ 0, and ϕR t ≥ 0, such that ϕS t + ϕI t +
ϕR t ≡ 1, for all t ∈ −τ, 0 . The formal derivation of system
(15) is given in [7, 8].
3.1.3. ANYboost. We assume that the immune system is
boosted to any better immunity level with uniform proba-
bility. That is, p z, v = p > 0 with p = 1/ zmax − v , for all
z ∈ v, zmax . The boosting matrix for the numerical imple-
mentation is shown in Figure 3(a).
3.1.4. HKboost and ODboost. Previous works have proposed
nonmonotonic functions for modeling the immune response
to secondary exposure. In [6, 13], a mathematical model for
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in-host dynamics during measles infection was proposed.
The model explicitly considers the relation between the
immune level at time of exposure and the level of memory
cells after exposure. Heﬀernan and Keeling [6, 13] suggest
that this relation is nonmonotonic. Indeed, although the level
of immunity after exposure is always greater than the level at
the time of exposure, the boosted level starts high, decreases,
and then increases again. We shall denote by HKboost the
boosting function from [6, 13]. For the numerical implemen-
tation of HKboost, we ﬁrst extract values from Figure 2(d) in
[6], which shows the relation between the initial and the
updated immune status. Then, we normalize the immune
status interval ( zmin, zmax = 0, 1 ) and extend the boosting
function to [0.75, 1], assuming that for high initial immune
status, the immune system is always boosted to the maximal
level (see Figure 3(b)). In terms of our model coeﬃcients, for
any initial immunity v, the atomic measure of the updated
immunity is concentrated on f v , where f is the boosting
function represented by the dotted curve in Figure 3(b).
The corresponding boosting matrix is shown in Figure 3(d).
Immune boosting in pertussis was considered in [14],
where a nonmonotonic boosting function similar to the one
in [6, 13] was proposed. The relation between the level of
memory cells before (v) and after (z) reexposure is governed
by the function
z = f v = v 1 + 15v
5
, with v ∈ 0, 5 16
De Graaf et al. [14] suggest that a small jump from v to z
corresponds to a mild infection that causes no harm but only
boosts the antibody level of the individual, whereas a large
jump corresponds to a severe infection that may also cause
disease. We shall use the boosting function in (16) for
simulations, previous normalization to zmin, zmax = 0, 1 ,
and small modiﬁcations which allow to have boundedness.
In detail, we assume that for very low initial immunity
(0 ≤ v < 0 075) and for large initial immunity (0 8 < v ≤ 1),
the immune status is always boosted to the maximal level
z = zmax = 1, whereas for v ∈ 0 075, 0 8 , the boosting prob-
ability is atomic along the graph of the boosting function
f in (16), as above. The resulting boosting function is
given by the solid curve in Figure 3(b), and the corresponding
boosting matrix is shown in Figure 3(c).
The two mechanisms for immune response HKboost and
ODboost are governed by rather similar boosting mecha-
nisms, and we shall see that the solutions behave accordingly.
3.2. Parameter Values. For the numerical computations
below, we set the birth rate, natural death rate d = 0 02, and
the initial conditions ψ0 z = 0 05 for z ∈ zmin, zmax = 0, 1 ,
I0 = 0 01, and S0 = 0 94. This means that we assume that
1% of the total population is infectious at the beginning
of our observations, while 5% is immune to the pathogen
and the level of immunity is equally distributed.
Concerning the disease dynamics, we set γ = 3 and
g z = 0 5, for all z ∈ zmin, zmax , corresponding to τ = 2
when the model can be reduced to DDE.
We allow the basic reproduction number R0 as given
in (6) to vary, in order to show both solutions that con-
verge to an endemic equilibrium and solutions that produce
periodic oscillations.
3.3. Stable Endemic Equilibrium. When the basic reproduc-
tion number is suﬃciently small, the solution converges to
an endemic equilibrium for all the boosting mechanisms pre-
sented in Section 3.1. We compare in Figure 4 the numerical
solution corresponding to diﬀerent boosting mechanisms. In
Figure 4(a), we show the component I of the solution, which
indicates how the number of infective evolves in time and
rapidly converges to an equilibrium. Changing the boosting
mechanism has small eﬀects on the infective population:
numerical solutions show the same qualitative behavior,
with endemic equilibria deviating less than 1% from each
other. In particular, we see that the nonmonotonic boost-
ing mechanisms, ODboost, HKboost, and ANYboost, yield
quantitatively equivalent solutions for the infective popula-
tion. The latter solution curves are bounded from below
by the solution of MAXboost and from above by the solution
of the NOboost problem.
In Figure 4(b), for each boosting mechanism, we visualize
the stationary distribution r z corresponding to the endemic
equilibrium in Figure 4(a). This indicates how immunity is
distributed among the R-population at the endemic equilib-
rium. It is visible that the choice of the boosting mechanism
importantly aﬀects the stationary distribution. To under-
stand why this happens, let us consider the case of a constant
immune decay rate, g z = ĝ, for all z ∈ zmin, zmax . For
certain choices of the probability density function, p one
can calculate the stationary distribution r z explicitly. For
example, in the absence of immune boosts (NOboost),
we have
r z = γI
∗
ĝ
e− d/ĝ zmax−z , 17
where I∗ is an endemic equilibrium of the systems (3) and
(10), with boundary condition (5).
In case of boosts to maximal immune level (MAXboost),
from (13) and (14), we have
r z = I
∗
ĝ
γ + β 1 − 1
R0
− I∗ e− d+βI
∗/ĝ zmax−z , 18
with the basic reproduction number R0 = β/ γ + d , as in
(6). With the parameter values indicated in Section 3.2, and
R0 = 1 5, the curves in (18) and (17) are almost straight lines,
as it can be observed in Figure 4(b).
We use the analytic stationary solution (18) of systems
(3), (4), (13), and (14) to verify the order of “spatial” accuracy
(i.e., with respect to the variable z) of the numerical discreti-
zation. On diﬀerent meshes, we compute numerically the
stationary solution of the MAXboost systems (3), (4), (13),
and (14). Although we know the explicit solution for the
stationary distribution r, there is no explicit analytical for-
mulation for the endemic equilibrium I∗, which can only
be determined numerically (see also [7]). We ﬁx I∗ to the
value computed on the ﬁnest mesh (M = 14000 equidistant
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mesh points), and we insert this value into the (18) of the
stationary distribution. Then, we compute the maximum
error between the analytical and the numerical solutions
on diﬀerent mesh reﬁnements and observe that our method
preserves the second-order accuracy of the Lax-Wendroﬀ
scheme (see Figure 5).
3.4. Sustained Oscillations, Repeated Outbreaks. When
R0 = 5 and all other parameter values are as indicated in
Section 3.2, the systems (3), (4), and (5) show periodic oscil-
latory behavior, independent on the boosting mechanism. In
Figure 6, we compare the I component of the solution of the
systems (3), (4), and (5) for ﬁve diﬀerent immune responses.
Further, for all kinds of immune response, we compare in
Figure 7 the distribution of immune status among the
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Figure 5: Spatial accuracy of the numerical discretization, with
error represented in a log-log plot. The method is second-order
accurate.
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population for ﬁxed times (t = 1, 5, 10, 20 years) after the
beginning of the observation. Results illustrated in
Figures 6 and 7 and Table 1 indicate that also in the case
of periodic oscillations, the solutions of problems governed
by ODboost and HKboost are qualitatively and quantita-
tively equivalent (minor diﬀerences might be due to
computational errors and we consider them negligible).
Therefore, in the following, we show only results related
to NOboost, ANYboost, MAXboost, and ODboost, which
characterize four diﬀerent immune responses with qualita-
tively diﬀerent results. Figure 8 shows the solution r t, z
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Figure 7: Comparison of the eﬀects of diﬀerent boosting mechanisms on the distribution of immunity r t∗, z at ﬁxed times t∗ = 1, 5,
10, 20 years after the beginning of the observations.
Table 1: Quantitative comparison of the periodic oscillatory
solutions (I component) for changing immune boost mechanism.
Oscillation amplitudes and periods, as well as lowest and highest
incidence values, are reported.
Amplitude Period Min (I) Max (I)
NOboost 0.3088 2.766 0.0169 0.3257
MAXboost 0.3588 3.4 0.0024 0.3612
ANYboost 0.3430 3.2 0.0036 0.3466
ODboost 0.4105 3.35 0.0023 0.4129
HKboost 0.3926 3.35 0.0024 0.3950
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with respect to time and immune status for the four
selected boosting mechanisms.
In Figure 9, we visualize the contour plots of the r
component of the solution for diﬀerent immune response
mechanisms. Entries of the solution matrix r are interpreted
as heights with respect to the z, t plane; isolines are
calculated and displayed using colors corresponding to the
colormap on the right.
In Figure 10, we compare the immune distribution r t, z
corresponding to diﬀerent levels of an outbreak, for diﬀerent
boosting mechanisms. Figure 10(a) shows four points on a
typical infective curve (I) which we shall consider for
comparison. Point A corresponds to the infection peak,
that is, the time point at which the infective population
is at its maximal value. Point B and point D correspond
to intermediate levels in the infective population, just after,
respectively, just before an outbreak peak. Point C corre-
sponds to the time point at which the infective population
is at its minimal level. We see in Figures 10(b)–10(e) that
the diﬀerent immune responses yield qualitatively similar
immune distributions with immunity waves moving from
right to left. At the infective peak (Figure 10(b)), following
primary infection and reexposure to the pathogen, most of
the population has a very high immune status (z ∈ 0 8, 1 )
which slowly decays, reaching the level at which most of
the population has a low to intermediate immune level
(z ∈ 0, 0 6 ) (Figure 10(d)). Just before a new outbreak,
most of the hosts have very low (z ∈ 0, 0 2 ) or very high
(z ∈ 0 8, 1 ) immunity (Figure 10(e)).
4. Conclusion
Understanding the role of immune system boosting due to
the interplay of in-host and between hosts dynamics is a
central point in immunoepidemiology of infectious diseases.
Employing the mathematical models (3), (4), and (5), in this
work, we have systematically investigated the eﬀects of
diﬀerent (in-host) immune responses at population level.
The boosting mechanisms studied here are in part taken or
inspired by previous literature, for example, on measles
[6, 13], pertussis [14], and inﬂuenza [15].
Our results indicate that the in-host immune response,
that is, the individual boosting mechanism, has important
eﬀects on the qualitative dynamics of the epidemics. The
numerical results show that observing the distribution
of immune level among recovered individuals, one can
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Figure 8: The r t, z solution for diﬀerent boosting mechanisms. (a) Waning immunity, absence of immune boosts. (b) Boost to maximal
level of immunity. (c) Uniform probability of boosting to any higher immunity level. (d) Nonlinear boost according to Figure 3(c).
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reconstruct the underlying boosting mechanism. When the
trajectories of the systems (3), (4), and (5) approach an
endemic equilibrium (Figure 4(b)), the distribution of
immunity uniquely identiﬁes the boosting mechanism gov-
erning the immune response in case of secondary infections.
Also for diseases with repeated outbreaks, it is possible to
infer the immune boosting mechanism from the temporal
evolution of immunity, though in this case, it is conve-
nient to look at the dynamic of the immune population
over time (Figures 8 and 9), rather than at the immune
distribution (Figure 10).
This paper presents a novel mathematical study of
temporal evolution of immune status in a population.
Despite the large number of publications in mathematical
epidemiology or mathematical immunology, to the best of
our knowledge, there have been only few authors who have
eﬀectively combined in-host dynamics and processes at
population level [6, 13, 16, 17], though only in [6, 13] the
temporal evolution of immunity has been considered. If we
compare the stationary distribution of immunity of HKboost
in Figure 4(b) with Figure 3(c) in [6], we observe that the
results are rather diﬀerent, the curve in [6] being smoother.
We conjecture that the diﬀerences are on the one hand
due to the choice of the parameters in the system, on the
other hand to the diﬀerent nature of the mathematical
models. In [6], a large system of ordinary diﬀerential equa-
tion is presented, including exposed hosts and immune
structure in all compartments, not only in the recovered
ones as it is in our work. Here, we focused on a simple
model for susceptible-infective-recovered dynamics in order
to understand the role of immune boosting and waning
immunity. We plan to extend the models (3), (4), and (5),
by means of physiologically structured susceptible and
exposed populations.
Parameter values used for all numerical simulations
presented in this work are not inspired by a speciﬁc infectious
disease, as we purely focused on the eﬀects of waning and
boosting. Nevertheless, the model is suitable to describe
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Figure 9: Contour plot of the r solution for diﬀerent boosting mechanisms. (a) Waning immunity, no boosts. (b) Boost to maximal level of
immunity. (c) Uniform probability of boosting to any higher immunity level. (d) Nonlinear boosting function as in Figure 3(c).
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several infectious diseases, prior proper choice of the param-
eters. Certain studies, for example [5, 18], introduced a fur-
ther parameter κ to express a relative force of infection for
reexposure, so they represent the rate of boosting by the term
(κβI). This is reasonable if we think that during contacts,
boosting occurs with a diﬀerent chance compared to primary
infection. In this paper, we have assumed that the force of
infection in secondary exposure is the same as in primary
exposure (κ = 1).
The in-host dynamics described in this paper is rather
coarse. The immune status of recovered individuals is repre-
sented by a single scalar quantity (z) which does not speciﬁ-
cally represent any kind of cells of the immune system. We
are aware of the fact that the immune system is indeed very
complex, and careful mathematical modeling should also
take into consideration nonlinear in-host processes and
interactions among the diﬀerent players of the innate and
adaptive immune system. Nevertheless, such a ﬁne descrip-
tion would quickly lead to a complicated mathematical
model, making it hard to achieve any reliable analytical or
numerical result at population level.
A further limitation of the model is the assumption on
the sharp threshold zmin, which deﬁnes the criterion for
transition from immune to susceptible compartment. It is
plausible that this transition does not occur in such an on-
oﬀ manner, but it is rather a continuous process; that is,
recovered individuals with a certain critically low level of
immunity are less likely to get immune boost and more likely
to experience a new infection, as suggested in [14]. Moreover,
it is known that the immune system is diﬀerently reactive at
diﬀerent life stages, in particular immune boosts are weaker
in children and elderly than in adults (see, e.g., the case of
pertussis considered in [19]). We plan to extend the model
including age heterogeneity.
Immune boosts occur not only after natural infection but
also in case of vaccine-induced immunity. Current vaccina-
tion schedules include “boosters” whose goal is the prolonga-
tion of protection against a certain pathogen [20]. The
mathematical models (3), (4), and (5) can be extended to
include vaccination and natural boosts induced in vaccinated
hosts by contact with infectives (see [21]). Similar investiga-
tion as proposed in this paper can be repeated in the context
of vaccination.
Our results indicate that immune system boosts from
natural secondary infections importantly aﬀect the immune
dynamics at population level. We hope that our ﬁndings will
stimulate future research in controlling infectious diseases
via vaccination and vaccine design.
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